Case Report
Author Details :
Volume : 7, Issue : 2, Year : 2022
Article Page : 85-89
https://doi.org/10.18231/j.ijirm.2022.020
Abstract
During the coronavirus disease 2019 (COVID-19) pandemic, increasing cases of COVID-19 associated mucormycosis (CAM) have been reported. This may be attributed directly to the COVID-19 infection or the associated unrecognised uncontrolled hyperglycaemia compounded by the use of COVID-19 treatment strategies such as steroids and IL-6 inhibitors. As mucormycosis is one of the most rapidly progressing fungal infection, an early diagnosis and early appropriate management are of prime importance in reducing mortality. Rhino-orbital-cerebral and pulmonary mucormycosis have been the most common presentations of CAM. Osteomyelitis in mucormycosis is very rare, although a few cases of maxillary bone involvement have been reported with CAM. We report a very rare and challenging case of extensive frontal bone osteomyelitis in a patient with CAM with frontal sinusitis and without orbital or maxillary bone involvement.
Keywords: Covid-19, Mucormycosis, Corticosteroids, Fungal infection, Amphotericin B
How to cite : Gupta N, Gupta R, Goel R, Gautam D, Singh V P, COVID-19 associated mucormycosis with frontal bone osteomyelitis. IP Indian J Immunol Respir Med 2022;7(2):85-89
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 07-04-2022
Accepted : 13-06-2022
Viewed: 965
PDF Downloaded: 273